Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 8;189(18):E669.
doi: 10.1503/cmaj.160967.

Inflammatory bowel disease in pregnancy

Affiliations

Inflammatory bowel disease in pregnancy

Amelie I Stritzke et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors are involved in a research project supported by the MSI Foundation and the American College of Gastroenterology regarding improving clinical pathways in IBD care during pregnancy. Cynthia Seow has received honoraria as an advisory board member for Janssen Pharmaceutical, AbbVie, Shire, Actavis, Takeda Canada and Ferring Pharmaceuticals; speaker fees from Janssen Pharmaceutical and AbbVie; and research and educational support from Janssen Pharmaceutical and AbbVie. No other competing interests were declared.

References

    1. The impact of inflammatory bowel disease in Canada: 2012 final report and recommendations. Toronto: Crohn’s and Colitis Foundation of Canada; 2012. Available: www.isupportibd.ca/pdf/ccfc-ibd-impact-report-2012.pdf (accessed 2016 Nov. 1).
    1. O’Toole A, Nwanne O, Tomlinson T. Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis. Dig Dis Sci 2015;60:2750–61. - PubMed
    1. de Lima A, Zelinkova Z, Mulders AG, et al. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol 2016;14:1285–92.e1. - PubMed
    1. Nguyen GC, Seow CH, Maxwell C, et al. IBD in Pregnancy Consensus Group; Canadian Association of Gastroenterology. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 2016;150:734–57.e1. - PubMed
    1. Julsgaard M, Christensen LA, Gibson PR, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology 2016;151: 110–9. - PubMed